Related Experiment Video
Updated: Apr 4, 2026

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy
Published on: October 31, 2025
Autoimmune statin-induced myopathy: a case report
Jonathan B Young1, Ibrahim I Ghobrial2
1Department of Medicine, UPMC McKeesport Hospital, McKeesport, PA, USA; youngjbmd@gmail.com.
A 58-year-old woman developed progressive muscle weakness due to necrotizing autoimmune myopathy, a condition potentially linked to statin use. This case highlights the importance of considering drug-induced myopathies in differential diagnoses.
Area of Science:
- Neurology
- Immunology
- Pharmacology
Background:
- Statin medications are widely prescribed for hyperlipidemia.
- Autoimmune myopathies are a group of rare disorders characterized by muscle inflammation and weakness.
- Necrotizing autoimmune myopathy (NAM) is a specific subtype of autoimmune myopathy.
Observation:
- A 58-year-old woman with a history of statin use reported a 4-month history of progressive proximal muscle weakness affecting her shoulders and thighs.
- Initial investigations, including laboratory tests and electromyography, indicated a generalized proximal myopathy.
- Conditions such as connective tissue disease, malignancy, and active viral infections were excluded.
Findings:
- Muscle biopsy results were consistent with necrotizing autoimmune myopathy.
- The findings suggest a potential association between statin use and the development of necrotizing autoimmune myopathy in this patient.
Implications:
- This case underscores the importance of considering statin-associated autoimmune myopathy in patients presenting with unexplained proximal muscle weakness.
- Further research is warranted to elucidate the precise mechanisms linking statins to necrotizing autoimmune myopathy.
- Early diagnosis and appropriate management, potentially including statin discontinuation and immunosuppressive therapy, are crucial for improving patient outcomes.
Related Concept Videos
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Myocarditis III: Medical Management
Myocarditis I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests